Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Total Liabilities (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Total Liabilities for 6 consecutive years, with $2.2 million as the latest value for Q3 2021.

  • Quarterly Total Liabilities rose 6.51% to $2.2 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Sep 2021, up 6.51% year-over-year, with the annual reading at $1.6 million for FY2020, 33.94% down from the prior year.
  • Total Liabilities for Q3 2021 was $2.2 million at ENDRA Life Sciences, down from $2.3 million in the prior quarter.
  • The five-year high for Total Liabilities was $2.4 million in Q4 2019, with the low at $162302.0 in Q2 2017.
  • Average Total Liabilities over 5 years is $1.5 million, with a median of $1.6 million recorded in 2020.
  • Peak annual rise in Total Liabilities hit 580.8% in 2018, while the deepest fall reached 55.31% in 2018.
  • Over 5 years, Total Liabilities stood at $848214.0 in 2017, then grew by 14.9% to $974583.0 in 2018, then surged by 147.86% to $2.4 million in 2019, then plummeted by 33.94% to $1.6 million in 2020, then surged by 35.25% to $2.2 million in 2021.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $2.2 million, $2.3 million, and $1.0 million for Q3 2021, Q2 2021, and Q1 2021 respectively.